local control

You have access
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma
SANG HOON SEO, JEONG IL YU, HEE CHUL PARK, GYU SANG YOO, MOON SEOK CHOI, HYUNCHUL RHIM, MIN WOO LEE, SEUNGCHUL HAN, BORAM PARK and JI SUN SHIM

Anticancer Research May 2024, 44 (5) 2219-2230; DOI: https://doi.org/10.21873/anticanres.17029
You have access
Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer
TOMOMI AOSHIKA, SHIN-EI NODA, TAKANORI ABE, YU KUMAZAKI, RYUTA HIRAI, MITSUNOBU IGARI, SATOSHI SAITO, YASUHIRO RYUNO, MISAKI IINO, YUGA TAKEDA, TOMOHIRO OHTA, JUN WATANABE, KEITA TSUKAHARA and SHINGO KATO

Anticancer Research April 2024, 44 (4) 1583-1589; DOI: https://doi.org/10.21873/anticanres.16956
Open Access
Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)
YOSHIHIRO KAWAI, SHUHEI ARAMAKI, TOMOSHIGE ISHIHARA, KOSUKE SUZUKI, TSUYOSHI OKAWA, ERIKO SATO, NAOFUMI OTA, TAKASHI KOSUGI, MORIKAZU AMANO and KENTA KONISHI

Anticancer Research October 2023, 43 (10) 4543-4549; DOI: https://doi.org/10.21873/anticanres.16648
You have access
Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma
OKSANA ZEMSKOVA, EUGENE PEDACHENKO, NATHAN Y. YU and DIRK RADES

Anticancer Research July 2023, 43 (7) 3121-3128; DOI: https://doi.org/10.21873/anticanres.16484
Open Access
Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy
OKSANA ZEMSKOVA, NATHAN Y. YU, PETER TRILLENBERG, MATTEO M. BONSANTO, JAN LEPPERT and DIRK RADES

Anticancer Research June 2023, 43 (6) 2725-2732; DOI: https://doi.org/10.21873/anticanres.16439
You have access
Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases
LEONIE JOHANNWERNER, ELISA M. WERNER, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES

Anticancer Research June 2023, 43 (6) 2757-2762; DOI: https://doi.org/10.21873/anticanres.16443
Open Access
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
PASCALE ALICIA HOELL, KHALED ELSAYAD, HENDRIK BERSSENBRUEGGE, DOMINIK HERING, CHRISTOPHER KITTEL, JOHANNES KLEINHEINZ, ANNALEN BLECKMANN, GEORG EVERS, EVA WARDELMANN, CLAUDIA RUDACK and HANS THEODOR EICH

Anticancer Research March 2023, 43 (3) 1255-1263; DOI: https://doi.org/10.21873/anticanres.16272
You have access
Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer
RYO-ICHI YOSHIMURA, KAZUMA TODA, HIROSHI WATANABE, ATSUSHI KAIDA, HIROYUKI HARADA, TAKAHIRO ASAKAGE and MASAHIKO MIURA

Anticancer Research December 2021, 41 (12) 6259-6266; DOI: https://doi.org/10.21873/anticanres.15446
You have access
Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck
JENS EISMANN, KHALED ELSAYAD, DANIEL ROLF, IQBAL SARIF, EVA WARDELMANN, HENDRIK BERSSENBRÜGGE, GEORG LENZ and HANS THEODOR EICH

Anticancer Research October 2021, 41 (10) 5131-5135; DOI: https://doi.org/10.21873/anticanres.15330
You have access
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728

Main menu

User menu

Search

local control

Pages